BROWNSTEIN HYATT FARBER SCHRECK, LLP

Lobbying for CAREDX, INC. · Molecular diagnostics

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $50,000.00 income · posted Jul 18, 2025

Lobbying activity 1

Health Issues

Use of bioscience markers with regard to organ transplant rejection

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem